RE:RE:RE:RE:Seeking Alpha on recent THTX development There are all kinds of liver diseases or medical conditions related to the liver. What if Egrifta is helpful in one or more of those. Like diabetes or high chloresterol? I believe MDGL is trying to show that their fat burning drug Resmetiron also helps in these areas. What if Egrifta has some fo the the same attributes?
I don't believe it will be useful in Diabetes.
"administration of pharmacological doses of rhGH is associated with a variety of adverse effects, including hyperglycemia, insulin resistance"
A study was done with Tesamorelin to see if it had simialar effects, which luckily it did not. It may be beneficial in lowering cholesterol though.
No significant differences were observed between groups in relative insulin response over the 12-week treatment period. At Week 12, fasting glucose, HbA1c and overall diabetes control were not significantly different between groups. In addition, relevant modifications in diabetes medications were similar between groups. Total cholesterol (-0.3±0.6 mmol/L) and non-HDL cholesterol (-0.3±0.5 mmol/L) significantly decreased from baseline to Week 12 in the tesamorelin 2 mg group (p<0.05 vs. placebo). No patient discontinued the study due to loss of diabetes control.